Diedrik Vermeulen is a co-founder of SiPhox and serves as its Chief Executive Officer. Diedrik brings more than 13 years of experience and pioneering work in integrated photonics to SiPhox. Prior to co-founding SiPhox, Diedrik was the Director of Engineering at Analog Photonics commercializing chip-scale LiDAR and tunable lasers.
He was a research scientist at Massachusetts Institute of Technology and previously worked at Acacia Communications bringing the first silicon photonics-based coherent transceiver for long-haul and metro optical fiber communication to market. Diedrik holds over 20 patents and has published more than 100 papers and conference contributions in letters, journals, and conferences which have received thousands of citations.
Human blood contains 3000 unique proteins which concentration profiles are powerful diagnostic markers. We are standing at the precipice of a proteomics revolution. Broad protein biomarker screening and machine learning have opened the possibility of understanding and even preventing chronic diseases as well as creating a feedback loop for the improvement of treatments. However, once relevant protein biomarker panels are discovered there is no compact, affordable technology that can longitudinally track how their levels vary in an individual over time. We will show how SiPhox is leveraging the existing CMOS and optical transceiver infrastructure towards the miniaturization and democratization of longitudinal proteomic analysis.